Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$150.03+1.97 (+1.33%)
Close on Nov 11, 2026Market cap $10.41BP/E 24.4Yield –
Insulet ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Insulet's ebitda for the twelve months ending Sep 30, 2026 was $693.40M, up 32.2% year over year. For fiscal 2025 it was $564.20M, up 44.8% from the year before. The highest annual figure on record is $564.20M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $564.20M | +44.8% |
| FY2024 | Dec 31, 2024 | $389.70M | +33.0% |
| FY2023 | Dec 31, 2023 | $292.90M | +190.6% |
| FY2022 | Dec 31, 2022 | $100.80M | -45.0% |
| FY2021 | Dec 31, 2021 | $183.40M | +71.6% |
| FY2020 | Dec 31, 2020 | $106.90M | +37.2% |
| FY2019 | Dec 31, 2019 | $77.90M | +81.2% |
| FY2018 | Dec 31, 2018 | $43.00M | +561.5% |
| FY2017 | Dec 31, 2017 | $6.50M | +107.7% |
| FY2016 | Dec 31, 2016 | $3.13M | – |
| FY2015 | Dec 31, 2015 | -$32.90M | -1082.3% |
| FY2014 | Dec 31, 2014 | $3.35M | – |
| FY2013 | Dec 31, 2013 | -$17.33M | – |
| FY2012 | Dec 31, 2012 | -$24.94M | – |
| FY2011 | Dec 31, 2011 | -$33.96M | – |
| FY2010 | Dec 31, 2010 | -$33.56M | – |
| FY2009 | Dec 31, 2009 | -$54.14M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $218.00M | +56.0% |
| Q2 FY2026 | Jun 30, 2026 | $156.40M | +9.1% |
| Q1 FY2026 | Mar 31, 2026 | $148.30M | +34.2% |
| Q4 FY2025 | Dec 31, 2025 | $170.70M | +30.5% |
| Q3 FY2025 | Sep 30, 2025 | $139.70M | +27.7% |
| Q2 FY2025 | Jun 30, 2025 | $143.40M | +94.6% |
| Q1 FY2025 | Mar 31, 2025 | $110.50M | +46.0% |
| Q4 FY2024 | Dec 31, 2024 | $130.80M | +4.4% |
| Q3 FY2024 | Sep 30, 2024 | $109.40M | +48.8% |
| Q2 FY2024 | Jun 30, 2024 | $73.70M | +49.8% |
| Q1 FY2024 | Mar 31, 2024 | $75.70M | +68.6% |
| Q4 FY2023 | Dec 31, 2023 | $125.30M | +215.6% |
| Q3 FY2023 | Sep 30, 2023 | $73.50M | +291.0% |
| Q2 FY2023 | Jun 30, 2023 | $49.20M | – |
| Q1 FY2023 | Mar 31, 2023 | $44.90M | -15.6% |
| Q4 FY2022 | Dec 31, 2022 | $39.70M | -38.5% |
| Q3 FY2022 | Sep 30, 2022 | $18.80M | -61.0% |
| Q2 FY2022 | Jun 30, 2022 | -$10.90M | -126.3% |
| Q1 FY2022 | Mar 31, 2022 | $53.20M | +82.8% |
| Q4 FY2021 | Dec 31, 2021 | $64.60M | +251.1% |
| Q3 FY2021 | Sep 30, 2021 | $48.20M | +38.9% |
| Q2 FY2021 | Jun 30, 2021 | $41.50M | +11.0% |
| Q1 FY2021 | Mar 31, 2021 | $29.10M | +77.4% |
| Q4 FY2020 | Dec 31, 2020 | $18.40M | -32.4% |
| Q3 FY2020 | Sep 30, 2020 | $34.70M | +39.9% |
| Q2 FY2020 | Jun 30, 2020 | $37.40M | +177.0% |
| Q1 FY2020 | Mar 31, 2020 | $16.40M | +32.3% |
| Q4 FY2019 | Dec 31, 2019 | $27.20M | +32.2% |
| Q3 FY2019 | Sep 30, 2019 | $24.80M | +125.7% |
| Q2 FY2019 | Jun 30, 2019 | $13.50M | +70.2% |
| Q1 FY2019 | Mar 31, 2019 | $12.40M | +252.1% |
| Q4 FY2018 | Dec 31, 2018 | $20.58M | +691.8% |
| Q3 FY2018 | Sep 30, 2018 | $10.99M | +87.1% |
| Q2 FY2018 | Jun 30, 2018 | $7.93M | +30415.4% |
| Q1 FY2018 | Mar 31, 2018 | $3.52M | – |
| Q4 FY2017 | Dec 31, 2017 | $2.60M | – |
| Q3 FY2017 | Sep 30, 2017 | $5.87M | – |
| Q2 FY2017 | Jun 30, 2017 | $26.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.99M | – |
| Q4 FY2016 | Dec 31, 2016 | -$776.00K | – |
See a number that looks wrong?